Back to results
CompletedPhase 3

SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer

NCT03294330

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Emory University Hospital

Atlanta, Georgia, United States

+2 additional locations

View on ClinicalTrials.gov